Sector: Healthcare · Industry: Biotechnology
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
Headquarters: Cheyenne, WY · Employees: 284 · Website: https://www.evbiologics.com
Yulong Eco-Materials Ltd (YECO) is a publicly traded company in the Healthcare sector (Biotechnology). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Competitors of Yulong Eco-Materials Ltd (YECO) tracked by Macroplane include GENERAL ELECTRIC CO (GE), RTX Corp (RTX), LINDE PLC (LIN), Toyota Motor Corp. (7203.T), BHP Group Ltd (BHP), BOEING CO (BA), RIO TINTO PLC (RIO), Airbus SE (AIR.PA), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets